Dont forget that Ambrian Capital, StoneBridge and BGF equities have all put buy recommendations on this stocks with targets of around $1, they cant all be wrong :)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago